Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Yuki · SciRah

Researcher profile · Semantic Scholar

S. Yuki

Share profile

S. Yuki — researcher profile on SciRah

h-index: 26
Works: 424
Citations: 2,436

Most-cited papers

Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors
Yoshiaki Nakamura, Hiroshi Ozaki, M. Ueno, Y. Komatsu +25 more
2024Nature Medicine55 citations Open access
Semantic Scholar
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
Y. Tsukada, H. Bando, K. Inamori, M. Wakabayashi +19 more
2024British Journal of Cancer30 citations Open access
Semantic Scholar
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
T. Hashimoto, Yoshiaki Nakamura, T. Fujisawa, Mitsuho Imai +37 more
2024Cancer Discovery23 citations Open access
Semantic Scholar
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
K. Hagio, J. Kikuchi, K. Takada, H. Tanabe +20 more
2023Cancer Science18 citations Open access
Semantic Scholar
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR‐SCREEN‐2 Study
T. Hashimoto, N. Iida, Yoshiaki Nakamura, Norio Nonomura +25 more
2025Cancer Science14 citations Open access
Semantic Scholar
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program
Yoshiaki Nakamura, Riu Yamashita, W. Okamoto, Y. Komatsu +32 more
2023JCO Precision Oncology11 citations Open access
Semantic Scholar
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)
K. Ando, Yoshiaki Nakamura, H. Kitao, M. Shimokawa +24 more
2023British Journal of Cancer11 citations Open access
Semantic Scholar
Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial
Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, W. Okamoto +16 more
2025JCO Precision Oncology10 citations Open access
Semantic Scholar
Survival outcomes and functional results of VOLTAGE-A: Preoperative chemoradiotherapy (CRT) and consolidation nivolumab (nivo) in patients (pts) with both microsatellite stable (MSS) and microsatellite instability–high (MSI-H) locally advanced rectal cancer (LARC).
Y. Tsukada, H. Bando, K. Inamori, M. Wakabayashi +15 more
2023Journal of Clinical Oncology9 citations
Semantic Scholar
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
A. Ueda, S. Yuki, Takayuki Ando, A. Hosokawa +13 more
2024Cancers8 citations Open access
Semantic Scholar
Anti-epidermal growth factor receptor treatment for patients with NeoRAS wild-type metastatic colorectal cancer: a case report of two cases
K. Harada, S. Yuki, Y. Kawamoto, Takeaki Nakamura +4 more
2023Therapeutic Advances in Medical Oncology8 citations Open access
Semantic Scholar
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)
K. Harada, T. Yamamura, O. Muto, M. Nakamura +15 more
2023Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials.
Y. Kagawa, H. Taniguchi, D. Kotani, T. Hashimoto +16 more
2025Journal of Clinical Oncology6 citations
Semantic Scholar
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors
T. Hashimoto, Yoshiaki Nakamura, Y. Komatsu, S. Yuki +26 more
2024BJC Reports6 citations Open access
Semantic Scholar
Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
K. Shitara, M. Hirao, S. Iwasa, T. Oshima +14 more
2023Clinical Cancer Research5 citations Open access
Semantic Scholar
P-172 VOLTAGE cohort D: Preoperative chemoradiotherapy followed by consolidation nivolumab plus ipilimumab in patients with locally advanced rectal cancer
Y. Takahashi, T. Kato, H. Bando, Y. Tsukada +16 more
2023Annals of Oncology5 citations Open access
Semantic Scholar
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study
S. Yuki, K. Yamazaki, Y. Sunakawa, H. Taniguchi +17 more
2023Cancer Medicine4 citations Open access
Semantic Scholar
FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancer
T. Hashimoto, N. Iida, S. Kadowaki, A. Makiyama +21 more
2025ESMO Open3 citations
Semantic Scholar
Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma
Takeaki Nakamura, K. Hatanaka, Y. Kawamoto, S. Kaneko +6 more
2025Journal of Cancer Research and Clinical Oncology3 citations Open access
Semantic Scholar
A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)
M. Wakabayashi, H. Taniguchi, A. Makiyama, Y. Sunakawa +12 more
2025ESMO Open3 citations Open access
Semantic Scholar
Prospective observational study investigating the impact of treatment sequence using regorafenib and FTD/TPI for metastatic colorectal cancer on overall survival (OSERO study).
A. Chida, T. Kawakami, T. Hamano, T. Masuishi +16 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Artificial intelligence (AI)-powered HER2 quantification continuous score (QCS) and tumor microenvironment (TME) analysis in HER2-amplified metastatic colorectal cancer (mCRC) treated with pertuzumab plus trastuzumab.
Mitsuho Imai, Yoshiaki Nakamura, W. Okamoto, T. Kato +16 more
2023JCO Global Oncology3 citations Open access
Semantic Scholar
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
T. Kajiwara, T. Nishina, Riu Yamashita, Yoshiaki Nakamura +12 more
2023Cancers3 citations Open access
Semantic Scholar
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer.
C. Inagaki, R. Matoba, S. Yuki, M. Shiozawa +6 more
2023Future Oncology3 citations
Semantic Scholar
Predictors of the early discontinuation of anamorelin hydrochloride in gastrointestinal cancer-related cachexia: a multicenter retrospective cohort study (HGCSG2201)
K. Harada, Shinya Kajiura, K. Sawada, K. Hatanaka +17 more
2026Supportive Care in Cancer2 citations
Semantic Scholar
An observational/translational study to conduct real-world evidence and develop biomarkers of fruquintinib for patients with metastatic colorectal cancer (mCRC): FruBLOOM trial (JACCRO CC-19).
Y. Sunakawa, Chiaki Inagaki, S. Yuki, K. Ouchi +6 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Results of a phase 2 trial of ramucirumab plus docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903).
K. Sawada, Yasuyuki Kawamoto, K. Harada, Takayuki Ando +16 more
2025Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study.
S. Yuki, K. Yamazaki, Y. Sunakawa, H. Taniguchi +17 more
2024Clinical colorectal cancer2 citations Open access
Semantic Scholar
A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801
H. Nakatsumi, Y. Komatsu, K. Harada, Y. Kawamoto +17 more
2024International Journal of Cancer2 citations Open access
Semantic Scholar
VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancer
H. Bando, Y. Tsukada, S. Kumagai, Y. Miyashita +20 more
2024ESMO gastrointestinal oncology2 citations Open access
Semantic Scholar
Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in BRAF V600E-mutated metastatic colorectal cancer: GI-SCREEN post-hoc analysis
M. Imai, Y. Nakamura, T. Denda, Y. Komatsu +18 more
2023ESMO gastrointestinal oncology2 citations Open access
Semantic Scholar
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study
D. Kotani, E. Inoue, T. Denda, Chiaki Inagaki +14 more
2026The Oncologist1 citations Open access
Semantic Scholar
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors
K. Seguchi, T. Fujisawa, Sadakatsu Ikeda, Yu Oyama +18 more
2026Clinical Cancer Research1 citations Open access
Semantic Scholar
Safety run-in results from C-SOLVE (JACCRO GC-12): A randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in patients with HER2-negative, CLDN18.2-positive unresectable advanced gastric or GEJ cancer.
H. Kawakami, S. Yuki, R. Kawabata, Sho Sato +16 more
2026Journal of Clinical Oncology1 citations Open access
Semantic Scholar
JAGUAR (JACCRO PM-01): A prospective study to evaluate the clinical utility of serial comprehensive genomic profiling testing using circulating tumor DNA in patients with metastatic colorectal cancer.
Y. Sunakawa, T. Masuishi, Hiroyuki Takeda, Sho Umegaki +12 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar
Clinical validation of plasma circulating-tumor DNA assay using highly sensitive Safe-SeqS technology for detecting RAS and BRAF V600E in metastatic colorectal cancer.
Y. Miyashita, H. Bando, J. Watanabe, Y. Suwa +15 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
A retrospective observational study to evaluate the efficacy of trifluridine/tipiracil ± bevacizumab in metastatic colorectal cancer with MSI-high/deficient MMR.
R. Inamoto, Hiroko Hasegawa, K. Sugiyama, N. Izawa +7 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
35P Clinical outcomes of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab by metastasis status in RAS/BRAF wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13)
Y. Sunakawa, M. Shiozawa, Y. Shindo, Y. Ishikawa +16 more
2025Annals of Oncology1 citations
Semantic Scholar
777P Spatial transcriptomic dynamics of the tumour microenvironment after chemoradiotherapy followed by immune checkpoint blockade in locally advanced rectal cancer: A translational study from VOLTAGE trial
H. Bando, S. Kumagai, Y. Tsukada, S. Lee +15 more
2025Annals of Oncology1 citations Open access
Semantic Scholar
Neoadjuvant ONO-4578, an EP4 antagonist, in combination with nivolumab after chemoradiation therapy in locally advanced resectable rectal cancer.
Y. Takahashi, T. Kato, T. Yoshino, H. Bando +6 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
594P The efficacy of anti-EGFR therapy for RAS mutant metastatic colorectal cancer (mCRC) patients with RAS mutation negative in circulating-tumor DNA (ctDNA) after 1st- or 2nd-line chemotherapy
N. Izawa, T. Kudo, S. Yuki, M. Nakamura +16 more
2023Annals of Oncology1 citations
Semantic Scholar
CA125 kinetics as a potential biomarker for ascites progression during taxane plus ramucirumab therapy in patients with advanced gastric cancer.
A. Ueda, S. Yuki, T. Ando, I. Motoo +12 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant
Chikako Nakai, S. Mimaki, K. Matsushima, E. Shinozaki +21 more
2023International Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Retrospective analysis of drug intake affecting the intestinal microbiota and the therapeutic effects of chemotherapy on gastric cancer.
Takeaki Nakamura, Ryosuke Watanabe, T. Yamamura, K. Harada +4 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
for use
Y. Komatsu, S. Yuki, S. Sogabe, H. Fukushima +14 more
20231 citations
Semantic Scholar
Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer
S. Yuki, H. Kawakami, K. Harada, Yohei Kubota +8 more
2026BMC Cancer0 citations Open access
Semantic Scholar
606P Efficacy of capeOX plus nivolumab in patients with early relapsed HER2-negative gastric cancer: Results from the phase II JACCRO GC-11 (FirSTAR) trial
H. Arai, H. Takahashi, M. Tsuda, O. Muto +16 more
2026Annals of Oncology0 citations Open access
Semantic Scholar
A multicenter retrospective study on the clinical features of patients with human epidermal growth factor receptor 2-positive colorectal cancer (HGCSG2304).
S. Kaneko, K. Sawada, K. Hatanaka, M. Dazai +19 more
2026International Journal of Clinical Oncology0 citations Open access
Semantic Scholar
A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study.
T. Kawakami, T. Masuishi, T. Hamano, A. Chida +17 more
2026British Journal of Cancer0 citations
Semantic Scholar
CA125 kinetics as a marker for tumor progression during chemotherapy in patients with pancreatic cancer
I. Motoo, Takayuki Ando, A. Ueda, Ayumu Hosokawa +15 more
2026Scientific Reports0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Nishina×15
Invite
T. Nishina — researcher profile on SciRah
K. Harada×14
Invite
K. Harada — researcher profile on SciRah
Y. Komatsu×13
Invite
Y. Komatsu — researcher profile on SciRah
Y. Sunakawa×12
Invite
Y. Sunakawa — researcher profile on SciRah

×12

Invite

Y. Komatsu — researcher profile on SciRah

Invite

T. Esaki — researcher profile on SciRah

Invite

T. Kato — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah

Invite

Y. Kawamoto — researcher profile on SciRah

H. Taniguchi×8

Invite

H. Taniguchi — researcher profile on SciRah

Invite

H. Yasui — researcher profile on SciRah